Next, qPCR analysis revealed that the expression of G6PC3, SLC37A2, and SLC37A4 was considerably higher in all four glioma cell lines tested when compared to HepG2 cells (Figure 4B). This evidence concerns the gene G6PC3 and central nervous system cancer.